Perception and management of cancer predisposition in pediatric cancer centers: A European-wide questionnaire-based survey.
Jelena LazicOskar A HaasUgur ÖzbekTim RippergerAnna ByrjalsenGeertruij Te Kronnienull nullPublished in: Pediatric blood & cancer (2023)
The European Union-funded COST Action (LEukaemia GENe Discovery by data sharing, mining, and collaboration) LEGEND was an international and multidisciplinary collaboration between clinicians and researchers that covered a range of aspects of genetic predisposition in childhood leukemia. Within this framework, we explored the perception and handling of genetic predisposition in the daily practice of European treatment centers. Herein, we present the results of our questionnaire-based survey. We found that the overall awareness is quite high, and respondents remarked that identification and treatment of the most common predisposition syndromes were present. Nevertheless, high demand for continuous education and routinely updated resources remains.
Keyphrases
- cross sectional
- papillary thyroid
- healthcare
- genome wide
- copy number
- primary care
- childhood cancer
- small molecule
- acute myeloid leukemia
- quality improvement
- squamous cell carcinoma
- high throughput
- bone marrow
- social media
- electronic health record
- dna methylation
- combination therapy
- patient reported
- deep learning
- artificial intelligence
- smoking cessation